Literature DB >> 19522024

Predictive value of multi-detector computed tomography for accurate diagnosis of serous cystadenoma: radiologic-pathologic correlation.

Anjuli A Shah1, Nisha I Sainani, Avinash Ramesh Kambadakone, Zarine K Shah, Vikram Deshpande, Peter F Hahn, Dushyant V Sahani.   

Abstract

AIM: To identify multi-detector computed tomography (MDCT) features most predictive of serous cystadenomas (SCAs), correlating with histopathology, and to study the impact of cyst size and MDCT technique on reader performance.
METHODS: The MDCT scans of 164 patients with surgically verified pancreatic cystic lesions were reviewed by two readers to study the predictive value of various morphological features for establishing a diagnosis of SCAs. Accuracy in lesion characterization and reader confidence were correlated with lesion size (<or= 3 cm or >or= 3 cm) and scanning protocols (dedicated vs routine).
RESULTS: 28/164 cysts (mean size, 39 mm; range, 8-92 mm) were diagnosed as SCA on pathology. The MDCT features predictive of diagnosis of SCA were microcystic appearance (22/28, 78.6%), surface lobulations (25/28, 89.3%) and central scar (9/28, 32.4%). Stepwise logistic regression analysis showed that only microcystic appearance was significant for CT diagnosis of SCA (P = 0.0001). The sensitivity, specificity and PPV of central scar and of combined microcystic appearance and lobulations were 32.4%/100%/100% and 68%/100%/100%, respectively. The reader confidence was higher for lesions > 3 cm (P = 0.02) and for MDCT scans performed using thin collimation (1.25-2.5 mm) compared to routine 5 mm collimation exams (P > 0.05).
CONCLUSION: Central scar on MDCT is diagnostic of SCA but is seen in only one third of SCAs. Microcystic morphology is the most significant CT feature in diagnosis of SCA. A combination of microcystic appearance and surface lobulations offers accuracy comparable to central scar with higher sensitivity.

Entities:  

Mesh:

Year:  2009        PMID: 19522024      PMCID: PMC2695889          DOI: 10.3748/wjg.15.2739

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Management of cystic neoplasms of the pancreas.

Authors:  J C Box; H O Douglas
Journal:  Am Surg       Date:  2000-05       Impact factor: 0.688

2.  Cystic pancreatic masses: cross-sectional imaging observations and serial follow-up.

Authors:  A J Megibow; F P Lombardo; A Guarise; G Carbognin; J Scholes; N M Rofsky; M Macari; E J Balthazar; C Procacci
Journal:  Abdom Imaging       Date:  2001 Nov-Dec

3.  Serous microcystic adenoma (glycogen-rich cystadenoma) of the pancreas: study of 11 cases showing clinicopathological and immunohistochemical correlations.

Authors:  Yumiko Yasuhara; Noriko Sakaida; Yoshiko Uemura; Hideto Senzaki; Nobuaki Shikata; Airo Tsubura
Journal:  Pathol Int       Date:  2002-04       Impact factor: 2.534

4.  An aggressive resectional approach to cystic neoplasms of the pancreas.

Authors:  K D Horvath; J A Chabot
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

5.  CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment?

Authors:  C A Curry; J Eng; K M Horton; B Urban; S Siegelman; B S Kuszyk; E K Fishman
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

6.  Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa?

Authors:  Claudio Bassi; Roberto Salvia; Enrico Molinari; Carlo Biasutti; Massimo Falconi; Paolo Pederzoli
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

Review 7.  CT of serous cystadenoma of the pancreas and mimicking masses.

Authors:  Hyoung Jung Kim; Dong Ho Lee; Young Tae Ko; Joo Won Lim; Hyun Cheol Kim; Kyoung Won Kim
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

Review 8.  Risk of malignancy in serous cystic neoplasms of the pancreas.

Authors:  Oliver Strobel; Kaspar Z'graggen; Friedrich H Schmitz-Winnenthal; Helmut Friess; Andreas Kappeler; Arthur Zimmermann; Waldemar Uhl; Markus W Büchler
Journal:  Digestion       Date:  2003-08-29       Impact factor: 3.216

9.  Macrocystic serous adenoma of the pancreas: radiologic-pathologic correlation.

Authors:  Bharti Khurana; Koenraad J Mortelé; Jonathan Glickman; Stuart G Silverman; Pablo R Ros
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

10.  Discrimination of unilocular macrocystic serous cystadenoma from pancreatic pseudocyst and mucinous cystadenoma with CT: initial observations.

Authors:  Frank Cohen-Scali; Valérie Vilgrain; Giuseppe Brancatelli; Pascal Hammel; Marie-Pierre Vullierme; Alain Sauvanet; Yves Menu
Journal:  Radiology       Date:  2003-09       Impact factor: 11.105

View more
  5 in total

1.  Incidental Cystic Lesions in the Pancreas: Resect? EUS? Follow?

Authors:  Linda S Lee
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

Review 2.  Current perspectives on pancreatic serous cystic neoplasms: Diagnosis, management and beyond.

Authors:  Xiao-Peng Zhang; Zhong-Xun Yu; Yu-Pei Zhao; Meng-Hua Dai
Journal:  World J Gastrointest Surg       Date:  2016-03-27

3.  Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report.

Authors:  Gennaro Nappo; Niccola Funel; Simone Giudici; Paola Spaggiari; Giovanni Capretti; Silvia Carrara; Giovanna Pepe; Alessandro Zerbi
Journal:  BMC Surg       Date:  2020-12-14       Impact factor: 2.102

4.  Giant Serous Cystadenoma of the Pancreas (⩾10 cm): The Clinical Features and CT Findings.

Authors:  Qing-Yu Liu; Jun Zhou; Yu-Rong Zeng; Xiao-Feng Lin; Jun Min
Journal:  Gastroenterol Res Pract       Date:  2016-08-16       Impact factor: 2.260

Review 5.  Serous pancreatic neoplasia, data and review.

Authors:  Christoph F Dietrich; Yi Dong; Christian Jenssen; Valentina Ciaravino; Michael Hocke; Wen-Ping Wang; Eike Burmester; Kathleen Moeller; Nathan Ss Atkinson; Paola Capelli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.